Identification of novel core genes involved in malignant transformation of inflamed colon tissue using a computational biology approach and verification in murine models
Find out more Decus Healing #ScienceAndSpirituality #energymedicine #sacredgeometry #EarlyDetectionMatters #ScientificBreakthrough #ScientificInnovation To view or add a comment, sign in Innovative Drug Delivery Approaches for GLP-1 Agonists: Enhancing Medication Adherence & Treatment Outcomes: Nasrin Mahmoudi, PharmD, PhD, and Michael Baumann, highlight recent developments in GLP-1 agonist formulations and delivery methods, including advanced injectable formulations, novel oral delivery systems, and topical formulations
He holds shares in P1vital and acted as expert witness for Lilly
Additional information Edited by G Melino Rights and permissions About this article Cite this article Eldridge, A., O'Brien, T
Butler, A., Hoffman, P., Smibert, P., Papalexi, E
Important distinction: IGF-1 LR3 is not FDA-approved for any indication